CXCL1 and neoplasm: In this context, tumor cells with high IL-7R expression may co-opt IL-7 signaling to promote the enrichment of immunosuppressive TAM via CXCL1-dependent mechanisms; this process counteracts the potential immunostimulatory effects of IL-7.